Four companies that may buck the trend

At a time when the markets appear nervous, it would be advisable to look to companies that reported attractive growth during the first quarter of the current financial year in the hope the trend extends itself.
 
This column reviews stocks that caught my attention, warranting a closer scrutiny when they announce their second quarter results.
 
Camson Biotech: For long, those who bought into the stock lived on hope. It appears their patience might start paying off. Revenues have transformed: From Rs 2.05 crore in the first quarter of 2016-17 to Rs 11.27 crore in the first quarter of